Vanillylmandelic Acid (VMA) Urine – 24 Hrs & Spot Test

Medically Reviewed by: Dr. Dipak Ladda, M.D.

Expertise: Consultant Pathologist

Last Updated: July 24, 2026

Medical Analysis

Comprehensive Clinical Guide to Vanillylmandelic Acid (VMA) Urine Testing, Endocrinology, and Diagnostic Biomarkers

Introduction and Biochemical Properties of Vanillylmandelic Acid (VMA)

Vanillylmandelic acid (VMA) is formally defined as 3-methoxy, 4-hydroxymandelic acid, acting as the primary metabolic end product of catecholamines, specifically epinephrine and norepinephrine [1, 2]. These essential chemical compounds are formed within the liver and subsequently excreted in the urine [1, 2]. The precise measurement of VMA in urine serves as a crucial diagnostic test in clinical endocrinology [1, 2]. Catecholamines play an extremely important role as neurotransmitters or hormones [7]. They are produced predominantly by the adrenal medulla or the peripheral cellular system and are safely stored within specialized chromaffin cells [7]. These chromaffin cells rapidly release catecholamines into the circulation in physiological response to stress, physical injury, hypoxia, and other systemic stimuli [7].

Clinical Significance and Diagnostic Utility of VMA Testing

The primary clinical significance of VMA testing lies in its ability to detect rare endocrine malignancies and neural crest tumors [4, 7]. Specifically, it is utilized to detect pheochromocytoma, which is a rare tumor of the adrenal gland, and neuroblastoma, a malignant lesion primarily affecting pediatric populations [4, 7]. Furthermore, VMA estimation is utilized for continuous clinical monitoring, either to assess a patient’s response to active therapeutic interventions or to screen for disease recurrence [7]. Clinicians must always interpret the results of these tests strictly within the appropriate clinical context and alongside other relevant diagnostic investigations [7].

Clinical Indications for VMA Estimation and Tumor Screening

There are several core medical indications for ordering VMA estimations [7]. These include the routine screening of catecholamine-secreting tumors, neural crest tumor screening, and the comprehensive monitoring of central nervous system (CNS) tumors [3, 4, 7, 8]. Specific diagnostic targets encompass neuroblastoma, pheochromocytoma, ganglioneuroma, and CNS tumors in patients undergoing active clinical treatment [3, 4, 7, 8, 9].

Sample Collection Protocols and Patient Preparation Guidelines

Proper sample collection and rigorous patient preparation are vital for accurate VMA testing [1, 2]. For a 24-hour urine test, the laboratory requires a 10 ml aliquot, utilizing 10 ml of 50 percent nitric acid as a preservative. Patients must adhere to strict lifestyle restrictions: they must stop smoking 24 hours before the test, eliminate foods and liquids high in amines before 48 hours, eliminate high caffeine foods and liquids before 48 hours, and completely avoid vanilla and licorice. Furthermore, patients must avoid intense physical exercise and psychological stress during and immediately before the 24-hour collection period. Medications such as aspirin, pyridoxine, levodopa, amoxicillin, reserpine, and carbidopa must be discontinued for a full 2 weeks prior to the test. For a spot urine test, the sample requirement is 5 ml with a pH maintained below 3, adjusted using 6N HCl [2], though no special patient preparation is generally required, rendering it ideal strictly for basic monitoring and rapid screening purposes [2].

Methods of Estimation and Laboratory Techniques

Laboratories employ a wide array of advanced analytical methods for the estimation of VMA levels [1, 2]. These established techniques include the spectrophotometric method, paper chromatography, thin-layer chromatography, high-performance liquid chromatography (HPLC), enzyme-linked immunosorbent assay (ELISA), the colorimetric method, and specialized electrochemical detection methods, particularly when utilizing spot urine samples [1, 2].

Normal Reference Ranges and Age-Specific Laboratory Thresholds

Age (years)Normal Value (mg/g CRT)
0-20-27
3-50-13
6-99-13
>180-6

(Reference values adapted from standard biochemical testing guidelines [7])

Clinical Interpretation, False Positives, and Differential Diagnosis

Interpretation of VMA results requires extreme care [1, 7]. A positive test could be due to either a genetic or a nongenetic condition, and additional confirmatory testing is always required [1, 7]. Crucially, a normal result does not definitively exclude the presence of a catecholamine-secreting tumor, while elevated values are strongly suggestive of a catecholamine-secreting tumor but remain non-diagnostic on their own [1, 7]. For the absolute confirmation or precise differentiation of neuroblastoma, pheochromocytoma, or ganglioneuroma, clinicians must perform other specific diagnostic investigations [4, 7, 8, 9]. Moderate elevations in VMA can be seen in essential hypertension, intense anxiety, intense physical exercise, the consumption of certain herbal products, and complex drug-to-drug interactions [6, 7]. Conversely, levels are significantly high in cases of pheochromocytoma, ganglioneuroma, and neuroblastoma [4, 7, 8, 9]. Additionally, very low values of VMA can present with clinical manifestations such as food cravings, fatigue, low blood pressure, low muscle tone, exercise intolerance, and depression. Comprehensive pediatric and preanalytical evaluations must also account for minimal physiological and emotional distress, absence of hypertensive emergency or severe illness, overnight fasting, sample collection after at least 20 minutes of comfortable supine rest, ideal stress-free sampling for infants, and potential confounders such as creatinine correction, body mass index (BMI), muscle mass, physical exercise, and diet, while utilizing advanced LC-MS/MS platforms and avoiding standard immunoassays [1, 2, 7].

For Non-Medicos

Understanding Your Vanillylmandelic Acid (VMA) Urine Test and Hormone Health

What Is Vanillylmandelic Acid (VMA)?

Vanillylmandelic acid, commonly known as VMA, is a chemical byproduct that your body creates after breaking down stress hormones called catecholamines (epinephrine and norepinephrine) [1, 2]. These hormones are produced by your adrenal glands and nervous system when you experience stress, physical activity, or injury [7]. Your liver processes these hormones and sends them out through your urine, making urine tests a great way to measure them [1, 2].

Why Is the VMA Test Done?

Doctors order this test primarily to screen for and monitor rare tumors that produce excess stress hormones [4, 7]. These include pheochromocytoma (a rare adrenal gland tumor) and neuroblastoma (a type of nerve tissue cancer most commonly found in children) [4, 7]. It is also used to check if treatments for these conditions are working or if a tumor has returned [7].

How to Prepare and Collect Your Urine Sample

Preparing for a 24-hour VMA urine test requires careful planning. You must stop smoking for 24 hours, avoid foods high in amines and caffeine for 48 hours, and completely steer clear of vanilla and licorice. You must also avoid exercise and stress, and talk to your doctor about stopping certain medications like aspirin or cold medicines up to two weeks in advance. A special preservative is added to your collection container to keep the urine stable. Spot urine tests require less preparation and are mostly used for quick check-ups [2].

What Do Your Test Results Mean?

Normal VMA values vary by age, usually measured in milligrams per gram of creatinine, with adults typically showing levels between 0 and 6 mg/g CRT [7]. Moderate increases can be caused by everyday factors like intense anxiety, high blood pressure, heavy exercise, or certain herbal products [6, 7]. Significantly high levels point toward tumors like pheochromocytoma or neuroblastoma [4, 7, 8, 9], whereas very low levels can sometimes be linked to fatigue, low blood pressure, muscle weakness, or depression. Because many things can affect these levels, doctors always use additional tests to confirm a diagnosis [1, 7].

References:

  1. Tohmola, N., Itkonen, O., Turpeinen, U., Joenväärä, S., Renkonen, R., & Hämäläinen, E. (2015). Preanalytical validation and reference values for a mass spectrometric assay of serum vanillylmandelic acid for screening of catecholamine secreting neuroendocrine tumors. Clinica Chimica Acta, 446, 206–212. https://doi.org/10.1016/j.cca.2015.03.041 Cited by: 25

  2. Shen, Y., Lu, J., Tang, Q., Guan, Q., Sun, Z., Li, H., & Cheng, L. (2015). Rapid, easy analysis of urinary vanillylmandelic acid for diagnostic testing of pheochromocytoma by liquid chromatography tandem mass spectrometry. Journal of Chromatography B, 1002, 92–97. https://doi.org/10.1016/j.jchromb.2015.08.013 Cited by: 29

  3. Shrestha, R. (n.d.). Assessment of Urinary VMA Levels in Suspected Pediatric Cases of Catecholamines Produing Neurochromaffin Tumors. Cited by: 1

  4. Kavalakatt, S., & Ivica, J. (2026). HVA and VMA as neuroblastoma biomarkers. Biochemia Medica, 36(2), 020505.

  5. Chin, S. N. (2011). The predictive value of urinary vanillylmandelic acid testing in the diagnosis of phaeochromocytoma at the University Hospital of the West Indies. West Indian Medical Journal. Cited by: 1

  6. Sheps, S. G., Tyce, G. M., Flock, E. V., & Maher, F. T. (1966). Current experience in the diagnosis of pheochromocytoma. Circulation, 34(3), 473–483. https://doi.org/10.1161/01.cir.34.3.473 Cited by: 61

  7. Eisenhofer, G., Peitzsch, M., Bechmann, N., & Huebner, A. (2022). Biochemical diagnosis of catecholamine-producing tumors of childhood: Neuroblastoma, pheochromocytoma and paraganglioma. Frontiers in Endocrinology, 13, 901760. https://doi.org/10.3389/fendo.2022.901760 Cited by: 48

  8. Steen, C. (2014). An unusual case of a composite pheochromocytoma with neuroblastoma. Journal of Endocrinology and Metabolism, 4(3-4), 114–119. https://doi.org/10.14740/jem211w Cited by: 5

  9. Wang, J., Zhang, X., & Yang, Y. (2017). Composite pheochromocytoma/ganglioneuroblastoma of the adrenal gland: A case report and review of literature. International Journal of Clinical and Experimental Medicine, 10(3), 4740–4747.

FAQ’s:

  • What is vanillylmandelic acid?
    It is a metabolic end product of catecholamines, specifically epinephrine and norepinephrine, excreted in urine
    .

  • Why is the VMA test done?
    To screen for catecholamine-secreting tumors like pheochromocytoma, neuroblastoma, and ganglioneuroma
    .

  • How is a 24-hour sample collected?
    Using a 10 ml aliquot with 50 percent nitric acid as a preservative
    .

  • What dietary restrictions are required?
    Avoid high amines, caffeine, vanilla, and licorice before the urine collection test
    .

  • Which medications should be stopped?
    Stop aspirin, levodopa, amoxicillin, and other listed drugs for two weeks prior
    .

  • What methods estimate VMA levels?
    Methods include spectrophotometry, chromatography, HPLC, colorimetry, and ELISA testing
    .

  • What are normal VMA values?
    Normal values vary by age, ranging between 0-27 mg/g CRT for young children and 0-6 for adults
    .

  • Can normal results miss tumors?
    Yes, a normal result does not exclude the presence of a catecholamine-secreting tumor
    .

  • What causes moderate test elevations?
    Essential hypertension, intense anxiety, vigorous exercise, certain herbal products, and drug interactions
    .

What symptoms indicate very low values?
Symptoms include craving, fatigue, low blood pressure, low muscle tone, and exercise intolerance
.

Related Tests

 

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top